Can response to induction chemotherapy be a predictive marker for ultimate outcome in hypopharyngeal cancer

作者: Myung Woul Han , In Sun Ryu , Sang-Wook Lee , Sung-Bae Kim , Jong-Lyel Roh

DOI: 10.1177/0194599811420357

关键词: Induction chemotherapyPredictive markerIn patientOncologyChemoradiotherapyMedicineMultivariate analysisRetrospective cohort studyStatistical differenceInternal medicineHypopharyngeal cancer

摘要: Objective Induction chemotherapy (ICT) may reduce rates of distant metastases and enhance organ preservation survival in patients with hypopharyngeal cancer. The authors compared data who underwent chemoradiotherapy or surgery after ICT investigated whether response to is a predictive marker for outcome Study design Historical cohort study. Setting Tertiary-care hospital. Subjects methods enrolled 97 (89 men, 8 women; mean age 61.2 years; range, 29-80 years) previously untreated cancer between January 1997 December 2006 at Asan Medical Center. Disease-free (DFS), overall (OS), laryngectomy-free (LFS) were analyzed. Results At follow-up 38.0 months, the 3-year DFS OS all 48.3% 49.2%, respectively. LFS rate nonsurgical therapy (n = 85) was 48.0%. Only associated (P .047), .003), .009) multivariate analysis. When surgical treatments ICT, they found that there no statistical difference terms partial (42.9% vs 50.5%, P .77) nonresponse groups (50.0% 0%, .43) 2 treatment types. Conclusion permits assessment tumor responsiveness alters subsequent accordingly. Response be useful prediction ultimate outcomes conservation

参考文章(25)
Nikolaos Zamboglou, George Fountzilas, Thomas Zaramboukas, Anna Kalogera-Fountzila, Konstantine T Kalogeras, Paris Kosmidis, Georgia Karayannopoulou, Mattheos Bobos, Eleni Athanassiou, Despina Misailidou, Aristotelis Bamias, Pavlos Papakostas, Christos Tolis, Periklis Tsekeris, Chrysanthi Vamvouka, Induction chemotherapy with docetaxel and cisplatin followed by concomitant chemoradiotherapy in patients with inoperable non-nasopharyngeal carcinoma of the head and neck Anticancer Research. ,vol. 29, pp. 529- 538 ,(2009)
Bipin T. Varghese, Paul Sebastian, Aleyamma Mathew, Treatment outcome in patients undergoing surgery for carcinoma larynx and hypopharynx: a follow-up study. Acta Oto-laryngologica. ,vol. 129, pp. 1480- 1485 ,(2009) , 10.3109/00016480902748520
Andreas Dietz, Volker Rudat, Jens Dreyhaupt, Maria Pritsch, Florian Hoppe, Rudolph Hagen, Leo Pfreundner, Ursula Schröder, Hans Eckel, Markus Hess, Michael Schröder, Petra Schneider, Bünzel Jens, Hans P. Zenner, Jochen A. Werner, Rita Engenhardt-Cabillic, Bernhard Vanselow, Peter Plinkert, Marcus Niewald, Thomas Kuhnt, Wilfried Budach, Michael Flentje, Induction chemotherapy with paclitaxel and cisplatin followed by radiotherapy for larynx organ preservation in advanced laryngeal and hypopharyngeal cancer offers moderate late toxicity outcome (DeLOS-I-trial). European Archives of Oto-rhino-laryngology. ,vol. 266, pp. 1291- 1300 ,(2009) , 10.1007/S00405-008-0846-Y
Stephen F. Hall, Patti A. Groome, Jonathan Irish, Brian O'Sullivan, Radiotherapy or surgery for head and neck squamous cell cancer: establishing the baseline for hypopharyngeal carcinoma? Cancer. ,vol. 115, pp. 5711- 5722 ,(2009) , 10.1002/CNCR.24635
Matthew G. Fury, Jatin P. Shah, Induction chemotherapy in the management of head and neck cancer. Journal of Surgical Oncology. ,vol. 101, pp. 292- 298 ,(2010) , 10.1002/JSO.21438
Ozden Altundag, Ibrahim Gullu, Kadri Altundag, Suayib Yalcin, Enis Ozyar, Mustafa Cengiz, Fadil Akyol, Taskin Yucel, Sefik Hosal, Bulent Sozeri, Induction chemotherapy with cisplatin and 5-fluorouracil followed by chemoradiotherapy or radiotherapy alone in the treatment of locoregionally advanced resectable cancers of the larynx and hypopharynx: results of single-center study of 45 patients. Head and Neck-journal for The Sciences and Specialties of The Head and Neck. ,vol. 27, pp. 15- 21 ,(2005) , 10.1002/HED.20107
E.A. Eisenhauer, P. Therasse, J. Bogaerts, L.H. Schwartz, D. Sargent, R. Ford, J. Dancey, S. Arbuck, S. Gwyther, M. Mooney, L. Rubinstein, L. Shankar, L. Dodd, R. Kaplan, D. Lacombe, J. Verweij, New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1) European Journal of Cancer. ,vol. 45, pp. 228- 247 ,(2009) , 10.1016/J.EJCA.2008.10.026
K-C Soo, E-H Tan, J Wee, D Lim, B-C Tai, M-L Khoo, C Goh, S-S Leong, T Tan, K-W Fong, P Lu, A See, D Machin, Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: a randomised comparison British Journal of Cancer. ,vol. 93, pp. 279- 286 ,(2005) , 10.1038/SJ.BJC.6602696
Moon-Sing Lee, Hsu-Chueh Ho, Shih-Hsuan Hsiao, Juen-Haur Hwang, Ching-Chih Lee, Shih-Kai Hung, Treatment results and prognostic factors in locally advanced hypopharyngeal cancer. Acta Oto-laryngologica. ,vol. 128, pp. 103- 109 ,(2008) , 10.1080/00016480701387116
Tejpal Gupta, Supriya Chopra, Jai Prakash Agarwal, Sarbani-Ghosh Laskar, Anil K. D’cruz, Shyam K. Shrivastava, Ketayun A. Dinshaw, Squamous cell carcinoma of the hypopharynx: single-institution outcome analysis of a large cohort of patients treated with primary non-surgical approaches. Acta Oncologica. ,vol. 48, pp. 541- 548 ,(2009) , 10.1080/02841860802488839